Martin Hoogduijn

Martin Hoogduijn is an Associate Professor in the Department of Internal Medicine at Erasmus MC, a leading academic medical center in the Netherlands. His research is centered on advancing transplantation medicine through regenerative therapies and immunological insights.

His research interests span transplantation immunology, mesenchymal stem cells, organoid engineering, and machine perfusion technologies. He investigates how stem cell-based therapies can modulate immune responses and improve graft survival, with a focus on kidney transplantation. His group pioneers the use of kidney organoids for drug testing and regenerative applications, and explores biomarkers released during machine perfusion to predict transplant outcomes.

The recent publication trend highlights a strong interdisciplinary approach combining molecular biology, immunology, and clinical transplantation. Key themes include EPO delivery via engineered organoids, immune cell dynamics during organ preservation, and predictive biomarkers in perfusate. These works are published in top-tier journals such as American Journal of Transplantation and Stem Cell Research & Therapy.

While no specific scientific awards are listed, his extensive research output (163 publications) and leadership in innovative projects indicate significant recognition in the field. He has supervised 11 research projects, suggesting active mentorship of early-career scientists, though individual student names are not disclosed.

Dr. Hoogduijn is involved in advanced research on organ preservation, immune monitoring, and regenerative solutions for kidney disease. His team collaborates widely across Europe, focusing on translating lab-developed organoid and perfusion technologies into clinical practice.